Abstract

Introduction/BackgroundIn advanced epithelial ovarian cancer (AEOC) patients with unresectable disease in initial presentation neoadjuvant chemotherapy followed by interval cytoreduction is beneficial in improving patient survival. Cytoreductive surgery including extensive upper...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call